THIS ACTIVITY REQUIRES CREDIT CARD PAYMENT. If you ordered this product in advance, click Learning Search to locate the activity.
To enroll in the series with one easy payment, or to enroll multiple participants from the same institution, call 800-323-4040 option 1. This option is only available until December 31, 2020, after this date this activity is only accessible by an online credit card payment.
Molecular testing for oncology patients spans dozens of methods from simple allele-specific PCR to error-corrected next-generation sequencing. Oncologists are increasingly ordering “liquid biopsies,” a colloquial term for testing peripheral blood for biomarkers of inaccessible disease sites to help guide treatment planning, particularly for patients with lung cancer. This activity discusses current and near-future applications for cell-free, circulating tumor DNA testing.
This clinical pathology activity is intended for pathologists.
After completing this SAM eligible activity and posttest, you should be able to:
- Apply knowledge of cell free DNA (cfDNA) characteristics to practical considerations of sample collection.
- Compare and contrast available methodologies for performing cfDNA analysis.
- Weigh the benefits and risks of utilizing a liquid biopsy for cancer patients.
- Identify current recommendations for molecular biomarkers in management of non-small cell lung cancer (NSCLC) and most likely liquid biopsy targets for NSCLC in the future.
- Describe the most likely potential and future applications of cfDNA testing in oncology.
Clinical Pathology Improvement Program
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a
maximum of 1.25
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Pathology’s (ABPath) Continuing Certification (CC) requirements for Self-Assessment Modules (SAMs).
This activity meets the American Board of Pathology’s (ABPath) Continuing Certification (CC) requirements for Improvement in Medical Practice (IMP).
You have a total of three opportunities to take and pass the posttest. If you correctly answer 70% or more of the posttest items, you may claim credit. CME/SAM credit can be applied to the American Board of Pathology (ABPath) Self-Assessment Module (SAM) requirements. You must pass the posttest to claim credit; therefore, if you do not pass, you cannot claim any credit.
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.
College of American Pathologists
325 Waukegan Road
Northfield, IL 60093-2750
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at
email@example.com or fax at 847-832-8006.
Pop-up blockers must be turned off.
CAP Learning has recognized that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online assessment portion of this activity. If you experience difficulty or have any questions, please contact a representative of the CAP Learning Division at 800-323-4040 option 1 or firstname.lastname@example.org.
This activity and evaluation are available September 21, 2020, and expire September 20, 2023, at 12:00 AM (ET). You MUST claim credit by this date and time.